Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.’s drug epidemic

Today, the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s (FDA’s) final laboratory developed tests rule will impact patient access to essential tests. The survey found that, in spite of certain tests being exempt from the rule, it will still force many laboratories, particularly those in hospitals, to discontinue critical tests, including those needed to identify prescription and illegal drug use.

Anesthesiologists Denounce Another Year of Medicare Payment Cuts, Urge Immediate Reforms

The American Society of Anesthesiologists (ASA) condemned yet another year of cuts to Medicare payments for critically important anesthesia and pain medicine services. The proposed cuts, announced in the Centers for Medicare & Medicaid Services’ (CMS) 2024 Physician Fee Schedule (PFS), represent the fifth consecutive year of either a pay freeze or payment cut for the services anesthesiologists provide to their patients as shown in the table below. The CMS-proposed Medicare payment cuts will compound the financial strain anesthesia practices are already facing.

ASTRO supports CMS’ prior authorization reform for Medicare Advantage plans

The American Society for Radiation Oncology (ASTRO) issued the following statement from Geraldine M. Jacobson, MD, MBA, MPH, FASTRO, Board of Directors Chair, in response to yesterday’s final rule from the Centers for Medicare and Medicaid Services (CMS) that revises the Medicare Advantage prior authorization process.

Anesthesiologists Oppose 700% Increase in Fee to Access No Surprises Act Independent Dispute Resolution Process and Call for IDR Reforms

Today, the American Society of Anesthesiologists (ASA) expressed its outrage with the 700% surge in the No Surprises Act (NSA) administrative fee that must be paid by anesthesiologists to access the Federal Independent Dispute Resolution (IDR) system. ASA urges the government to block implementation of the massive fee increase and reform the IDR process.

AAOS Comments on Proposed Medicare Payment Policy Changes for 2023

The American Association of Orthopaedic Surgeons (AAOS) issued formal comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s proposed payment policy changes for Calendar Year (CY) 2023. In both letters, AAOS urged the agency to address growing health care costs, expand access to care and ease physician burden as they continue to navigate patient care, amidst financial and practice management challenges exacerbated by the pandemic.

New ASTRO letter to CMS outlines pathways to achieve value-based payment for radiation oncology

The American Society for Radiation Oncology delivered comments to CMS following a proposed indefinite delay for the radiation oncology APM. Recommendations outline actionable steps to stabilize Medicare reimbursement, prioritize health equity, reduce unnecessary administrative burden and improve cancer outcomes.

Senators and representatives unite to call on CMS to protect patient access to high-quality radiation treatments

Eighty-five members of Congress have joined together to issue bipartisan, bicameral oversight letters that call on CMS to scale back severe cuts to radiation therapy reimbursement. Without action from CMS, radiation oncology will face estimated cuts of $300 million starting January 1, 2022, jeopardizing patient access to care.

ASTRO submits comments to CMS: Stop the draconian cuts that will harm cancer patient care

The American Society for Radiation Oncology (ASTRO) submitted two comment letters to the Centers for Medicare and Medicaid Services (CMS) today urging the agency to reconsider policy changes that will result in $300 million in Medicare cuts for radiation therapy services starting January 1, 2022.

ASTRO applauds nominations of Chiquita Brooks-LaSure as CMS administrator and Elizabeth Fowler as CMMI director

The American Society for Radiation Oncology (ASTRO) today expressed its support for President Joseph R. Biden Jr.’s nomination of Chiquita Brooks-LaSure as administrator of the Centers for Medicare and Medicaid Services (CMS) and the appointment of Elizabeth Fowler as director of the Center for Medicare and Medicaid Innovation (CMMI).

Coffea speeds up particle physics data analysis

The prodigious amount of data produced at the Large Hadron Collider presents a major challenge for data analysis. Coffea, a Python package developed by Fermilab researchers, speeds up computation and helps scientists work more efficiently. Around a dozen international LHC research groups now use Coffea, which draws on big data techniques used outside physics.

ASTRO responds to CMS Radiation Oncology Model: Implementation delay and more reforms needed

In response to today’s announcement by the Centers for Medicare and Medicaid Services (CMS) to establish an advanced alternative payment model (APM) for radiation oncology practices starting January 1, 2021, the American Society for Radiation Oncology (ASTRO) issued the following statement from Theodore L. DeWeese, MD, FASTRO, Chair of the ASTRO Board of Directors.

Congressional leaders support radiation oncology community concerns about proposed Medicare alternative payment model

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model). CMS is expected to issue its final determination before the end of 2019.